A Mayo-developed digital health company received the FDA's emergency use authorization for an algorithm that can detect heart failure in users.
Oncology
New York City-based Memorial Sloan Kettering Cancer Center ended the first quarter of 2020 with an operating loss, despite seeing revenue increase year over year, according to recently released financial documents.
Vaccines and anti-infectives are among the highest therapy priorities for U.S. health plans, according to a report from consulting and professional services firm ZS.
More than half of cancer researchers report that their work has been temporarily put on hold due to the coronavirus pandemic, according to a new survey.
A new artificial intelligence algorithm can accurately assess the risk of cancer associated with indeterminate pulmonary nodules in patients' lungs, according to a study published in American Journal of Respiratory and Critical Care Medicine.
Thomas Jefferson University will no longer purchase the Fox Chase Cancer Center from Temple University due to the "devastating economic impact of COVID-19."
The amount of Americans undergoing routine cancer screenings has plummeted during the pandemic, according to Epic data cited by STAT.
The costs of dozens of cancer drugs were about 2.3 times higher in the U.S. than in Europe even though they had similar clinical benefits, according to a study cited by STAT.
Researchers at Danville, Pa.-based Geisinger have successfully used a blood test to diagnose presymptomatic cancer patients for the first time, according to a study published in Science.